Kimberly Shriner

1.4k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Kimberly Shriner is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Kimberly Shriner has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 3 papers in Clinical Biochemistry. Recurrent topics in Kimberly Shriner's work include Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kimberly Shriner is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kimberly Shriner collaborates with scholars based in United States and Canada. Kimberly Shriner's co-authors include Annie Wong‐Beringer, Donald Hsu, Levita Hidayat, Ryan Quist, Veena Venugopalan, Matthew Bidwell Goetz, Glenn E. Mathisen, Brian D. Ross, Napapon Sailasuta and Michelle Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Kimberly Shriner

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections

2006 691 citations Levita Hidayat, Donald Hsu et al. Archives of Internal Medicine profile →

Peers

Kimberly Shriner

EPIDE

PHARM

Christopher W. Crank United States

Jennifer Hanrahan United States

Brian J. Werth United States

Donald H. Batts United States

Jennifer S. McDanel United States

Cosme Cruz United States

Jordan R. Smith United States

Katie E. Barber United States

Silvana Noviello Italy

Barry Hafkin United States

Christopher W. Crank United States

Kimberly Shriner

842 ×1.2

481 ×1.2

462 ×1.6

EPIDE

195 ×0.8

PHARM

168 ×0.8

Citations per year, relative to Kimberly Shriner Kimberly Shriner (= 1×) peers Christopher W. Crank

Countries citing papers authored by Kimberly Shriner

Since Specialization

Citations

This map shows the geographic impact of Kimberly Shriner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Shriner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Shriner more than expected).

Fields of papers citing papers by Kimberly Shriner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Shriner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Shriner. The network helps show where Kimberly Shriner may publish in the future.

Co-authorship network of co-authors of Kimberly Shriner

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Shriner. A scholar is included among the top collaborators of Kimberly Shriner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Shriner. Kimberly Shriner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lou, Mimi, et al.. (2022). Unvaccinated Non-Elderly Adult Population Hospitalized for COVID-19: Risk for Severe Disease and Poor Outcomes. Journal of Primary Care & Community Health. 13. 4267739298–4267739298.

Le, Diana, Mimi Lou, Emi Minejima, et al.. (2022). Temporal Dynamics of Host Immune Response Associated With Disease Severity and Time to Recovery in Patients Hospitalized for COVID-19. Critical Care Explorations. 4(9). e0760–e0760. 3 indexed citations

Lou, Mimi, et al.. (2021). Factors associated with prompt recovery among hospitalised patients with coronavirus disease 2019. International Journal of Clinical Practice. 75(11). e14818–e14818. 4 indexed citations

King, Kevin S., et al.. (2020). The association of nadir CD4-T cell count and endothelial dysfunction in a healthy HIV cohort without major cardiovascular risk factors. SHILAP Revista de lepidopterología. 8. 2107996892–2107996892. 9 indexed citations

Tran, Thao, et al.. (2018). Distinguishing Brain Impact of Aging and HIV Severity in Chronic HIV Using Multiparametric MR Imaging and MR Spectroscopy. Open Forum Infectious Diseases. 5(10). ofy243–ofy243. 6 indexed citations

Sullivan, Eva, et al.. (2013). Risk of Developing Pneumonia Is Enhanced by the Combined Traits of Fluoroquinolone Resistance and Type III Secretion Virulence in Respiratory Isolates of Pseudomonas aeruginosa*. Critical Care Medicine. 42(1). 48–56. 30 indexed citations

Yamaki, Jason, et al.. (2013). Early Response Assessment to Guide Management of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Vancomycin Therapy. Clinical Therapeutics. 35(7). 995–1004. 8 indexed citations

Yamaki, Jason, Michelle Lee, Kimberly Shriner, & Annie Wong‐Beringer. (2011). Can clinical and molecular epidemiologic parameters guide empiric treatment with vancomycin for methicillin-resistant Staphylococcus aureus infections?. Diagnostic Microbiology and Infectious Disease. 70(1). 124–130. 5 indexed citations

Venugopalan, Veena, Kimberly Shriner, & Annie Wong‐Beringer. (2010). Regulatory Oversight and Safety of Probiotic Use. Emerging infectious diseases. 16(11). 1661–1665. 153 indexed citations

10.

Wong‐Beringer, Annie, et al.. (2009). An Antimicrobial Stewardship Program with a Focus on Reducing Fluoroquinolone Overuse. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(6). 736–743. 43 indexed citations

11.

Sailasuta, Napapon, Kimberly Shriner, & Brian D. Ross. (2008). Evidence of reduced glutamate in the frontal lobe of HIV‐seropositive patients. NMR in Biomedicine. 22(3). 326–331. 34 indexed citations

12.

Nguyen, Long H., Donald Hsu, Vadivel Ganapathy, Kimberly Shriner, & Annie Wong‐Beringer. (2008). Reducing empirical use of fluoroquinolones for Pseudomonas aeruginosa infections improves outcome. Journal of Antimicrobial Chemotherapy. 61(3). 714–720. 13 indexed citations

13.

Hidayat, Levita, Donald Hsu, Ryan Quist, Kimberly Shriner, & Annie Wong‐Beringer. (2006). High-Dose Vancomycin Therapy for Methicillin-Resistant Staphylococcus aureus Infections. Archives of Internal Medicine. 166(19). 2138–2138. 691 indexed citations breakdown →

14.

Wong‐Beringer, Annie & Kimberly Shriner. (2000). Fluconazole‐Induced Agranulocytosis with Eosinophilia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(4). 484–486. 7 indexed citations

15.

Shriner, Kimberly & Matthew Bidwell Goetz. (1992). Severe hepatotoxicity in a patient receiving both acetaminophen and zidovudine. The American Journal of Medicine. 93(1). 94–96. 37 indexed citations

16.

Shriner, Kimberly, Glenn E. Mathisen, & Matthew Bidwell Goetz. (1992). Comparison of Mycobacterial Lymphadenitis Among Persons Infected with Human Immunodeficiency Virus and Seronegative Controls. Clinical Infectious Diseases. 15(4). 601–605. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact